Hirotaka Matsui

ORCID: 0000-0002-6266-3227
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Acute Myeloid Leukemia Research
  • Epigenetics and DNA Methylation
  • Amyloidosis: Diagnosis, Treatment, Outcomes
  • RNA modifications and cancer
  • RNA Research and Splicing
  • Protein Degradation and Inhibitors
  • Chronic Myeloid Leukemia Treatments
  • Acute Lymphoblastic Leukemia research
  • Chronic Lymphocytic Leukemia Research
  • RNA and protein synthesis mechanisms
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Hematopoietic Stem Cell Transplantation
  • Genomics and Chromatin Dynamics
  • Parathyroid Disorders and Treatments
  • Retinoids in leukemia and cellular processes
  • Hemoglobinopathies and Related Disorders
  • Peptidase Inhibition and Analysis
  • Immune Cell Function and Interaction
  • Lymphoma Diagnosis and Treatment
  • Cardiovascular Function and Risk Factors
  • Cell Adhesion Molecules Research
  • Cardiac Valve Diseases and Treatments
  • Immunodeficiency and Autoimmune Disorders
  • Monoclonal and Polyclonal Antibodies Research
  • HIV/AIDS drug development and treatment

Kumamoto University
2016-2025

The University of Tokyo
2014-2025

Tokyo National Hospital
2023-2025

National Cancer Center Hospital East
2023-2024

Toyohashi Municipal Hospital
2024

National Cancer Center
2024

Kumamoto University Hospital
2016-2023

Hiroshima University
2009-2019

Japanese Red Cross Nagoya Daiichi Hospital
2016-2018

Japanese Red Cross Nagoya Daini Hospital
2017-2018

Upon binding double-stranded DNA (dsDNA), cyclic GMP-AMP synthase (cGAS) is activated and initiates the cGAS-stimulator of IFN genes (STING)-type I interferon pathway. DEAD-box helicase 41 (DDX41) a helicase, mutations in DDX41 cause myelodysplastic syndromes (MDSs) acute myeloid leukemia (AML). Here, we show that DDX41-knockout (KO) cells have reduced type production after virus infection. Unexpectedly, activations cGAS STING are affected KO cells, suggesting functions upstream cGAS. The...

10.1016/j.celrep.2022.110856 article EN cc-by-nc-nd Cell Reports 2022-05-01

Comprehensive genomic profiling (CGP) is increasingly used as a clinical laboratory test and being applied to cancer treatment; however, standardization external quality assessments (EQA) have not been fully developed. This study performed cost-effective EQA proficiency tests (PT) for CGP testing among multiple institutions those belong the working group of Japan Association Clinical Laboratory Science (JACLS). revealed that preanalytical processes, such derived nucleic acids (NA) extraction...

10.1038/s41598-024-84714-4 article EN cc-by-nc-nd Scientific Reports 2025-01-07

Bcr-Abl kinase is known to reverse apoptosis of cytokine-dependent cells due cytokine deprivation, although it has been controversial whether chronic myeloid leukemia (CML) progenitors have the potential survive under conditions in which there are limited amounts cytokines. Here we demonstrate that early hematopoietic (Sca-1(+) c-Kit(+) Lin(-)) isolated from normal mice rapidly undergo absence In these cells, expression Bim, a proapoptotic relative Bcl-2 plays key role cytokine-mediated...

10.1128/mcb.24.14.6172-6183.2004 article EN Molecular and Cellular Biology 2004-06-29

The eleven-nineteen leukemia (ENL) protein family, composed of ENL and AF9, is a common component 3 transcriptional modulators: AF4-ENL-P-TEFb complex (AEP), DOT1L-AF10-ENL (referred to as the DOT1L complex) polycomb-repressive 1 (PRC1). Each associates with chromatin via distinct mechanisms, conferring different properties including activation, maintenance, repression. mixed-lineage (MLL) gene often fuses AF10 family genes in leukemia. However, functional interrelationship among those...

10.1172/jci91406 article EN Journal of Clinical Investigation 2017-04-09

Abstract Human papilloma virus (HPV)-associated oropharyngeal cancer (OPC) is an independent tumour type with regard to cellular, biological, and clinical features. The use of non-invasive biomarkers such as circulating DNA (ctDNA) may be relevant in early diagnosis eventually improve the outcomes patients head neck squamous cell carcinoma (HNSCC). Genome-wide discovery using RNA sequencing reduced representation bisulfite yielded 21 candidates for methylation-targeted genes. A verification...

10.1038/s41388-020-1327-z article EN cc-by Oncogene 2020-05-15

Abstract Myeloid malignancies with DDX41 mutations are often associated bone marrow failure and cytopenia before overt disease manifestation. However, the mechanisms underlying these specific conditions remain elusive. Here, we demonstrate that loss of function impairs efficient RNA splicing, resulting in DNA replication stress excess R-loop formation. Mechanistically, binds to 5′ splice site (5′SS) coding coordinates splicing transcriptional elongation; prevents splicing-coupled transient...

10.1038/s41375-022-01708-9 article EN cc-by Leukemia 2022-10-14

Telaprevir is a potent inhibitor of hepatitis C virus (HCV) NS3-4A protease. However, the emergence drug-resistant strains during therapy serious problem, and susceptibility resistant to interferon (IFN), as well details mutant in vivo, not known. We previously established an infectious model HCV using human hepatocyte chimeric mice. Using this system we investigated biological properties mode mutants by ultra-deep sequencing technology. Chimeric mice were injected with serum samples...

10.1002/hep.24460 article EN Hepatology 2011-05-30

Abstract Gene rearrangements generate MLL fusion genes, which can lead to aggressive leukemia. In most cases, fuses with a gene encoding component of the AEP (AF4 family/ENL family/P-TEFb) coactivator complex. MLL–AEP proteins constitutively activate their target genes immortalize haematopoietic progenitors. Here we show that and transcription through selectivity factor 1 (SL1), core pre-initiation complex (PIC) RNA polymerase I (RNAP1). The pSER domain AF4 family associates SL1 on chromatin...

10.1038/ncomms9869 article EN cc-by Nature Communications 2015-11-23
Coming Soon ...